IBIO vs PRLD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

IBIO

48.6
AI Score
VS
IBIO Wins

PRLD

42.5
AI Score

Investment Advisor Scores

IBIO

49score
Recommendation
HOLD

PRLD

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBIO PRLD Winner
Revenue 100,000 10.28M PRLD
Net Income -8.99M -24.31M IBIO
Net Margin -8993.0% -236.3% PRLD
Operating Income -15.40M -29.63M IBIO
ROE -15.9% -18.2% IBIO
ROA -14.0% -12.8% PRLD
Total Assets 64.39M 189.36M PRLD
Cash 28.67M 26.33M IBIO
Current Ratio 9.04 4.07 IBIO

Relative Price Performance (Last 90 Days)

IBIO 1M: -1.4% · 3M: -23.4% PRLD 1M: +72.6% · 3M: +54.8%

Current Technical Phase

IBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.7 · Price: $1.41

PRLD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.3% over 20 days), RSI 75

RSI (14): 74.6 · Price: $6.61

Fundamentals Snapshot

Metric IBIO PRLD
Market Cap
Forward P/E -4.6 -8.8
Trailing P/E
Revenue (TTM)
Revenue Growth 0.1% 0.4%
Gross Margin 1.0% 1.0%
Operating Margin -96.5% -2.7%
EPS -0.55 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.